Influenza Vaccine in Pregnancy Part 2
NCT00593970 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2019-02-22
Summary
Pregnant women have limited knowledge regarding influenza, its implications during pregnancy, and recommendations for vaccination during pregnancy. The researchers plan to distribute an information pamphlet to women in a prenatal clinic, offer the vaccine during prenatal visits, and then give a questionnaire on the postpartum floor assessing knowledge.
The researchers hypothesize that with education intervention, knowledge scores on the questionnaire will be higher than those from last year, when no education was provided.
Conditions
- Influenza
- Pregnancy
Sponsors & Collaborators
-
Unity Health Toronto
lead OTHER
Principal Investigators
-
Mark H Yudin, MD · Unity Health Toronto
Eligibility
- Min Age
- 14 Years
- Max Age
- 46 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2007-11-30
- Primary Completion
- 2013-10-31
- Completion
- 2013-10-31
Countries
- Canada
Study Locations
More Related Trials
-
Text Message Reminders for Influenza Vaccine in Pregnancy
NCT02428738 ·Status: COMPLETED
-
Novartis H1N1 Vaccine in Pregnant Women
NCT00992719 ·Status: COMPLETED ·Phase: PHASE2
-
Maternal and Fetal Outcomes Following Influenza Vaccination in Pregnancy
NCT04579822 ·Status: UNKNOWN
-
Response to Influenza Vaccine During Pregnancy
NCT03888989 ·Status: TERMINATED ·Phase: PHASE1
-
H1N1 Vaccine in Pregnant Women
NCT00963430 ·Status: COMPLETED ·Phase: PHASE2
-
Opting In vs Opting Out
NCT01233804 ·Status: COMPLETED ·Phase: NA
-
Evaluate the Immunogenicity and Safety of the 2011-2012 Vaccine Against Seasonal Influenza on Pregnant Women
NCT01577316 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
H1N1v Vaccination of Pregnant Women: A Longitudinal Cohort Study Characterizing Influenza A H1N1v Vaccination in Pregnant Women
NCT01012557 ·Status: COMPLETED ·Phase: NA
-
The Safety and Immune Response to Influenza Vaccination in Pregnant Women
NCT01514708 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Influenza Vaccination on IVF Outcomes - IVF
NCT02947217 ·Status: UNKNOWN ·Phase: PHASE4
-
Do Some Healthy Adults Consistently Have Systemic Reactions to Influenza Vaccines?
NCT02263027 ·Status: COMPLETED ·Phase: PHASE4
-
Impact of Influenza Vaccination in Pregnancy Video Education
NCT02151201 ·Status: COMPLETED ·Phase: NA
-
Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Elderly Subjects
NCT00329927 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Subjects 18 Years of Age or Older
NCT00329966 ·Status: COMPLETED ·Phase: PHASE2
-
Immunogenicity and Safety of a Vaccine Against Influenza (2010-2011 Northern Hemisphere Season, Intradermal Route)
NCT01138397 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Influenza Vaccination on Donor Egg Recipient Outcomes
NCT02946177 ·Status: UNKNOWN ·Phase: PHASE4
-
Afluria Pregnancy Registry
NCT03442582 ·Status: COMPLETED
-
Pivotal, Multicenter, Observer-Blind, Randomized Study of Influenza A (H1N1)2009 Monovalent Subunit Vaccine With and Without Adjuvant in Children Ages 6 to <36 Months
NCT00996307 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2007/2008) When Administered to NON Elderly AND Elderly Subjects
NCT00518726 ·Status: COMPLETED ·Phase: PHASE2
-
Influenza Vaccine in Pregnant Women
NCT00905125 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Immunogenicity Study of Influenza Vaccines in HIV-infected and HIV-uninfected Pregnant Women in Western Kenya
NCT01810731 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
Fluarix/ FluLaval/ Fluarix Quadrivalent/ FluLaval Quadrivalent Vaccine Pregnancy Registry
NCT02148211 ·Status: COMPLETED
-
Feasibility of Cocooning Immunization Strategy With Influenza Vaccine
NCT00570037 ·Status: COMPLETED ·Phase: NA
-
PregText: Feasibility of Monitoring Influenza Vaccine Safety in Pregnant Women Using Text Messaging
NCT01974050 ·Status: COMPLETED ·Phase: NA
-
Safety of a Influenza Vaccine Produced Either in Mammalian Cell Culture or in Embryonated Hen Eggs in Adults and Elderly With and Without Underlying Medical Conditions, and Immunogenicity in a Subset of Subjects With Underlying Medical Conditions
NCT00560066 ·Status: COMPLETED ·Phase: PHASE4